先声药业1月16日斥资5163.28万港元回购443.3万股
SIMCERE PHARMASIMCERE PHARMA(HK:02096) Zhi Tong Cai Jing·2026-01-16 10:46

Core Viewpoint - The company, Sinopharm Group (先声药业), announced a share buyback plan, indicating confidence in its financial health and future prospects [1] Group 1 - The company will repurchase 4.433 million shares [1] - The total expenditure for the buyback is HKD 51.6328 million [1] - The buyback is scheduled to take place on January 16, 2026 [1]